These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

500 related items for PubMed ID: 22838241

  • 1. Actinomycin D for methotrexate-failed low-risk gestational trophoblastic neoplasia.
    Lurain JR, Chapman-Davis E, Hoekstra AV, Schink JC.
    J Reprod Med; 2012; 57(7-8):283-7. PubMed ID: 22838241
    [Abstract] [Full Text] [Related]

  • 2. Treatment of nonmetastatic and metastatic low-risk gestational trophoblastic neoplasia: factors associated with resistance to single-agent methotrexate chemotherapy.
    Chapman-Davis E, Hoekstra AV, Rademaker AW, Schink JC, Lurain JR.
    Gynecol Oncol; 2012 Jun; 125(3):572-5. PubMed ID: 22449733
    [Abstract] [Full Text] [Related]

  • 3. Low-risk gestational trophoblastic neoplasia and methotrexate resistance: predictors of response to treatment with actinomycin D and need for combination chemotherapy.
    Growdon WB, Wolfberg AJ, Goldstein DP, Feltmate CM, Chinchilla ME, Lieberman ES, Berkowitz RS.
    J Reprod Med; 2010 Jun; 55(7-8):279-84. PubMed ID: 20795339
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Therapeutic evaluation of cisplatin, etoposide, and bleomycin chemotherapy regimen in high-risk gestational trophoblastic neoplasia].
    Song SQ, Zhang GN.
    Zhonghua Fu Chan Ke Za Zhi; 2012 Aug; 47(8):571-6. PubMed ID: 23141175
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Clinical epidemiology and management of gestational trophoblastic neoplasia in Hungary in the past 34 years.
    Fülöp V, Szigetvári I, Szepesi J, Végh G, Singh M, Berkowitz RS.
    J Reprod Med; 2012 Aug; 57(7-8):310-8. PubMed ID: 22838247
    [Abstract] [Full Text] [Related]

  • 10. Management of metastatic high-risk gestational trophoblastic neoplasia: FIGO stages II-IV: risk factor score > or = 7.
    Lurain JR, Singh DK, Schink JC.
    J Reprod Med; 2010 Aug; 55(5-6):199-207. PubMed ID: 20626175
    [Abstract] [Full Text] [Related]

  • 11. Is lack of response to single-agent chemotherapy in gestational trophoblastic disease associated with dose scheduling or chemotherapy resistance?
    Kohorn EI.
    Gynecol Oncol; 2002 Apr; 85(1):36-9. PubMed ID: 11925117
    [Abstract] [Full Text] [Related]

  • 12. Gestational trophoblastic disease: a 21-year review of the clinical experience at an Argentinean public hospital.
    Bianconi MI, Otero S, Moscheni O, Alvarez L, Storino C, Jankilevich G.
    J Reprod Med; 2012 Apr; 57(7-8):341-9. PubMed ID: 22838252
    [Abstract] [Full Text] [Related]

  • 13. Pulse methotrexate versus pulse actinomycin D in the treatment of low-risk gestational trophoblastic neoplasia.
    Yarandi F, Eftekhar Z, Shojaei H, Kanani S, Sharifi A, Hanjani P.
    Int J Gynaecol Obstet; 2008 Oct; 103(1):33-7. PubMed ID: 18632105
    [Abstract] [Full Text] [Related]

  • 14. The WHO score predicts treatment outcome in low risk gestational trophoblastic neoplasia patients treated with weekly intramuscular methotrexate.
    Gilani MM, Fariba B, Behtash N, Ghaemmaghami F, Moosavi AS, Rezayof E.
    J Cancer Res Ther; 2013 Oct; 9(1):38-43. PubMed ID: 23575072
    [Abstract] [Full Text] [Related]

  • 15. Management of drug resistant gestational trophoblastic neoplasia.
    Patel SM, Desai A.
    J Reprod Med; 2010 Oct; 55(7-8):296-300. PubMed ID: 20795341
    [Abstract] [Full Text] [Related]

  • 16. Primary treatment of metastatic high-risk gestational trophoblastic neoplasia with EMA-CO chemotherapy.
    Lurain JR, Singh DK, Schink JC.
    J Reprod Med; 2006 Oct; 51(10):767-72. PubMed ID: 17086804
    [Abstract] [Full Text] [Related]

  • 17. Relapse rate of patients with low-risk gestational trophoblastic tumor initially treated with single-agent chemotherapy.
    Matsui H, Suzuka K, Yamazawa K, Tanaka N, Mitsuhashi A, Seki K, Sekiya S.
    Gynecol Oncol; 2005 Mar; 96(3):616-20. PubMed ID: 15721402
    [Abstract] [Full Text] [Related]

  • 18. Single-agent pulse dactinomycin has only modest activity for methotrexate-resistant gestational trophoblastic neoplasia.
    Chen LM, Lengyel ER, Bethan Powell C.
    Gynecol Oncol; 2004 Jul; 94(1):204-7. PubMed ID: 15262143
    [Abstract] [Full Text] [Related]

  • 19. Methotrexate on a 21-day cycle for low-risk gestational trophoblastic neoplasia.
    Diaz J, Thomas MB, Paz-Pabon C, Hernandez E.
    J Reprod Med; 2012 Jul; 57(9-10):411-4. PubMed ID: 23091988
    [Abstract] [Full Text] [Related]

  • 20. Hepatic metastasis in gestational trophoblastic neoplasia: patient characteristics, prognostic factors, and outcomes.
    Barber EL, Schink JC, Lurain JR.
    J Reprod Med; 2014 Jul; 59(5-6):199-203. PubMed ID: 24937957
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.